Skip to main content
. 2018 Jan 27;29(1):19–26. doi: 10.1007/s13337-018-0424-x

Fig. 1.

Fig. 1

Schematic depicting the overall effect of HIV/HCV co-infection on progression of liver disease. TIMP1 (tissue inhibitors of metalloproteinase 1), COL1A1 (Collagen, type I, alpha 1), MMPs (matrix metalloproteinase), TRAIL (TNF-related apoptosis-inducing ligand), TGF-β (transforming growth factor beta), NFkB (nuclear factor kappa-B), ROS (reactive oxygen species), CCR5 (C–C chemokine receptor type 5)